Genmab — Januar 2020
-
Michel Yee fra Jefferies, kunne godt se Gilead lave en cd20/cd3 eller stor pipeline aftale med Genmab. Meget kort kommentar fra 25:30. https://players.brightcove.net/4090876629001/default_default/index.html?videoId=6120856326001
-
The CD38low natural killer cell line KHYG1 transiently expressing
CD16F158V in combination with daratumumab targets multiple
myeloma cells with minimal efector NK cell fratricide https://sci-hub.tw/https://link.springer.com/article/10.1007/s00262-019-02477-8 -
so
we are not the only ones thinking that Dara should be added to the drinking water
https://twitter.com/IMFjimMYELOMA/status/1215669209058799616
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
